Structure-activity relationships for 4-anilinoquinazolines as potent inhibitors at the ATP binding site of the epidermal growth factor receptor in vitro

被引:32
作者
Denny, WA [1 ]
Rewcastle, GW [1 ]
Bridges, AJ [1 ]
Fry, DW [1 ]
Kraker, AJ [1 ]
机构
[1] WARNER LAMBERT PARKE DAVIS,DIV PHARMACEUT RES,ANN ARBOR,MI 48109
关键词
4-anilinoquinazoline; epidermal growth factor receptor; enzyme inhibitor; growth signal transduction;
D O I
10.1111/j.1440-1681.1996.tb02752.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Structure-activity relationships are described for the inhibition of the tyrosine kinase activity (phosphorylation of a fragment of phospholipase C-g1) of the epidermal growth factor receptor (EGFR) by 4-anilinoquinazolines. These compounds are competitive inhibitors at the ATP binding site. 2. The preferred side chain is anilino-, substituted at the 3-position with small lipophilic groups. The quinazoline moiety is absolutely required for activity, but substituents on the quinazoline greatly modulate potency, with electron-donating groups favoured. The most potent analogue, the 6,7-dimethoxy derivative (compound 20), has an IC50 of 29 pmol/L and a very high selectivity for the EGFR over other tyrosine kinase enzymes. 3. The present study shows that it is possible to identify small molecules that are very potent, yet highly selective, inhibitors of a single component of the growth signal transduction pathway in cells.
引用
收藏
页码:424 / 427
页数:4
相关论文
共 20 条
  • [1] Tyrosine kinase inhibitors .8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor
    Bridges, AJ
    Zhou, H
    Cody, DR
    Rewcastle, GW
    McMichael, A
    Showalter, HDH
    Fry, DW
    Kraker, AJ
    Denny, WA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 267 - 276
  • [2] BURKE T R JR, 1992, Drugs of the Future, V17, P119
  • [3] PROTEIN-TYROSINE KINASE INHIBITION - MECHANISM-BASED DISCOVERY OF ANTITUMOR AGENTS
    CHANG, CJ
    GEAHLEN, RL
    [J]. JOURNAL OF NATURAL PRODUCTS, 1992, 55 (11): : 1529 - 1560
  • [4] Dobrusin EM, 1992, ANNU REP MED CHEM, V27, P169
  • [5] SIGNALING BY RECEPTOR TYROSINE KINASES
    FANTL, WJ
    JOHNSON, DE
    WILLIAMS, LT
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 : 453 - 481
  • [6] A SPECIFIC INHIBITOR OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR TYROSINE KINASE
    FRY, DW
    KRAKER, AJ
    MCMICHAEL, A
    AMBROSO, LA
    NELSON, JM
    LEOPOLD, WR
    CONNERS, RW
    BRIDGES, AJ
    [J]. SCIENCE, 1994, 265 (5175) : 1093 - 1095
  • [7] GEISSLER JF, 1992, CANCER RES, V52, P4492
  • [8] THE PROTEIN-KINASE FAMILY - CONSERVED FEATURES AND DEDUCED PHYLOGENY OF THE CATALYTIC DOMAINS
    HANKS, SK
    QUINN, AM
    HUNTER, T
    [J]. SCIENCE, 1988, 241 (4861) : 42 - 52
  • [9] HAYMAN MJ, 1991, CANCER CELL-MON REV, V3, P302
  • [10] NEU(C-ERBB2/HER2) AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) IN BREAST-CANCER
    JARDINES, L
    WEISS, M
    FOWBLE, B
    GREENE, M
    [J]. PATHOBIOLOGY, 1993, 61 (5-6) : 268 - 282